Stephanie Annett

Dr. Stephanie Annett is a Lecturer in the School of Pharmacy and Biomolecular Sciences at the Royal College of Surgeons Ireland (RCSI). She holds a Master of Pharmacy (First Class) from Queen's University Belfast (2008-2012) and a PhD in Molecular Pharmacology from the same institution (2013-2017). Her research focuses on the FKBP protein family, nucleic acid-based drugs, obesity-related diseases, and inflammatory conditions such as psoriasis. She has secured grants from organizations including Enterprise Ireland, the Health Education Authority, and the National Psoriasis Foundation.

• Education: MPharm (Queen's University Belfast, 2012), PhD in Molecular Pharmacology (Queen's University Belfast, 2017)

Her research interests span cancer stem cells, obesity-associated cancers, diabetes, and immunology. Notable contributions include work on FKBPL-based peptides targeting angiogenesis and therapeutic strategies for obesity and inflammatory diseases. She teaches in RCSI's MPharm program, leading the Year 3 module and the Cancer: Prevention and Control course.

• Grants: DEFLATE (Enterprise Ireland, 2023-2025), ImuPhile (2023-2025), and multiple projects addressing FKBPL's role in obesity and psoriasis.

Her lab investigates FKBPL's role in metabolic and inflammatory pathways, with a focus on translating findings into clinical therapeutics.